Unibest

Pharmaceutical intermediates

Beraprost Sodium Intermediates

1 pharmaceutical intermediate for Beraprost Sodium. Indication: Pulmonary hypertension; Peripheral vascular disease.

提交项目All intermediates

About Beraprost Sodium

Originator
Toray Industries, Inc.
Indication
Pulmonary hypertension; Peripheral vascular disease
Approved Date
12/17/1999

Available intermediates

1 intermediate currently listed for Beraprost Sodium. Request specifications, documentation or a quotation for any item below.

Beraprost Sodium intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
(1R,3R)-Cyclopent-4-ene-1,3-diol Monoacetate60410-17-5//

Other programs under B

Baloxavir MarboxilBaricitinibBDTX-1535Bedaquiline FumarateBelumosudil mesylateBelzutifanBempedoic acidBictegravir

Building toward Beraprost Sodium?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →